Search for: "WATSON PHARMACEUTICALS "
Results 41 - 60
of 360
Sorted by Relevance
|
Sort by Date
21 Sep 2015, 7:00 am
Just a few months after establishing this health and wellness cloud platform, IBM has secured its first Foundational Life Sciences partner for Watson Health in Teva Pharmaceutical Industries (NYSE:TEVA) of Petah Tikva, Israel. [read post]
1 Apr 2016, 5:30 am
The FTC’s complaint alleges that Endo paid the first generic companies that filed for FDA approval – Impax Laboratories, Inc. and Watson Laboratories, Inc. [read post]
3 May 2012, 6:07 pm
Orange County - Earlier this month, Watson Pharmaceuticals received a favorable ruling in a patent infringement lawsuit filed against it by Orange County-based Allergan. [read post]
11 Jul 2012, 9:50 pm
Watson Pharmaceuticals, Inc. [read post]
17 Aug 2014, 9:59 pm
Watson Laboratories Inc. 1:14-cv-01003; filed July 31, 2014 in the District Court of Delaware • Plaintiffs: Unimed Pharmaceuticals LLC; Besins Healthcare Luxemborg SARL • Defendant: Watson Laboratories Inc. [read post]
25 Mar 2009, 12:17 pm
From the March 25 MedWatch Alert: FDA and Watson Pharmaceuticals notified healthcare professionals and patients of a recall of Propafenone HCL 225 mg tablets, a drug product used to treat cardiac arrhythmias. [read post]
6 Mar 2007, 9:55 pm
By Donald Zuhn On Monday, Canadian pharmaceutical company Biovail (NYSE: BVF) announced that it had reached a comprehensive settlement with Anchen Pharmaceuticals, Impax Laboratories, Teva Pharmaceutical Industries, and Watson Pharmaceuticals with respect to Wellbutrin XL ® (bupropion HCl), a once-daily antidepressant which has a low incidence of sexual dysfunction, weight gain,... [read post]
26 Apr 2012, 9:18 pm
Florida; Watson Pharmaceuticals Inc.; Watson Pharma Inc. [read post]
15 Mar 2011, 9:56 pm
By James DeGiulio -- Watson Invalidates Cephalon's Fentora Patents Watson Pharmaceuticals won a substantial victory in its lawsuit with Cephalon over Fentora when the generic drugmaker successfully established that two of three asserted patents covering the drug are invalid. [read post]
20 Aug 2007, 12:04 am
Watson Pharmaceuticals, case no. 04-56791 (9th Cir. [read post]
9 Aug 2009, 10:02 pm
Watson Pharmaceuticals, Inc. [read post]
28 Jan 2015, 10:00 pm
Watson Pharmaceuticals, Inc., to the Federal Circuit “for further consideration in light of Teva Pharmaceuticals USA, Inc., v. [read post]
25 Apr 2013, 12:15 pm
Watson Pharmaceuticals, Inc., the Federal Circuit reversed the district court and held that Bayer’s patent covering its Yaz® birth control pill product is invalid as obvious. [read post]
2 Mar 2014, 8:47 pm
Watson Laboratories Inc. et al. 1:14-cv-00268; filed February 27, 2014 in the District Court of Delaware • Plaintiff: Takeda Pharmaceuticals USA Inc. [read post]
6 Jan 2010, 9:12 pm
Cephalon Inc. has filed a civil suit for patent infringement against the generic drugmaker Watson Pharmaceuticals Inc. for its analeptic drug Nuvigil, generically known as Armodafinil. [read post]
3 Feb 2009, 2:55 pm
The Federal Trade Commission has filed a complaint in federal district court challenging agreements by Solvay Pharmaceuticals, which paid generic drug makers Watson Pharmaceuticals and Par Pharmaceutical Companies to delay launching generic versions of Solvay's brand name testosterone-replacement drug AndroGel, a prescription pharmaceutical with annual sales of more than $400 million. [read post]
26 Jun 2009, 6:47 am
Week one of trial will conclude this week in Alabama (Montgomery County Circuit Court) in the state's prosecution of drug company Watson Pharmaceuticals for overpricing. [read post]
23 Nov 2010, 9:54 pm
Noonan -- The Federal Trade Commission is nothing if not persistent in trying to eliminate "reverse payment" settlements in ANDA litigation, even going so far as to "forum shop" to do so, according to a brief by appellees Unimed Pharmaceuticals LLC, Abbott Products, Inc., and Watson Pharmaceuticals, Inc. [read post]
9 Apr 2009, 9:14 pm
District Court for the District of Delaware has ruled that Watson Pharmaceuticals, Inc.'s generic version of Concerta ® (methylphenidate hydrochloride extended-release tablets) does not infringe ALZA Corporation's and McNeill-PPC's patent covering the drug. [read post]
25 Feb 2013, 11:00 pm
Watson Pharmaceuticals, Inc., the Federal Circuit reversed the district court’s finding that two Orange Book-listed patents for Cephalon’s FENTORA® product were invalid, but affirmed the district court’s finding that Watson’s ANDA product would not... [read post]
